≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Erythema nodosum

DOID EFO MESH SNOMED PheWeb

L12_ERYTHEMANODOSUM

erythema infectiosum: usually a benign childhood condition characterized by a classic slapped-cheek appearance (see the image below) and lacy exanthem.It results from infection with human parvovirus (PV) B19, an erythrovirus.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 L52
Hospital discharge: ICD-9 6952
Hospital discharge: ICD-8 69520
Cause of death: ICD-10 L52
Cause of death: ICD-9 6952
Cause of death: ICD-8 69520

2 out of 7 registries used, show all original rules.

836

diagram downward connector

Check minimum number of events None

836

diagram downward connector

Include endpoints None

836

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

814

diagram downward connector
L12_ERYTHEMANODOSUM

Control definitions

Control exclude L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L50-L54
Name in latin Erythema nodosum

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 814 643 171
Unadjusted prevalence (%) 0.22 0.31 0.10
Mean age at first event (years) 41.36 41.07 42.47

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 4.24 [2.45, 7.35] 2.4e-7 64
15 years 0.02 2.44 [1.50, 3.97] 3.2e-4 26
5 years 0.00 3.60 [2.05, 6.32] 8.0e-6 15
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: L12_ERYTHEMANODOSUM – Erythema nodosum
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Erythema nodosum
after Erythema nodosum

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Erythema nodosum

↥

Endpoint not on priority list, no data to show.